Wednesday, July 8, 2026

pharma · Advanced solid tumors · Advanced Solid Tumors · TTRX

Turn Therapeutics

Turn Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Westlake Village, USA HQ
2015 Founded
11 Employees
Public company Type
TTRX · NYSE Ticker
Company details
Status
Public
HQ
Westlake Village, USA
Founded
2015
Employees
11
Programs
6
Drugs
3
Patents
40
Intelligence · Clinical Trials

Turn Therapeutics clinical trials

Registry index of 6 ClinicalTrials.gov studies linked to Turn Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Turn Therapeutics trial registry — 6 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for Turn Therapeutics.

  1. TPX-0005-07 — Phase 2

    Clinical update
  2. CA177-1036 — Phase 1

    Clinical update
  3. GX-03 — Phase 2

    Clinical update
  4. Repotrectinib (TPX-0005) — Phase 2

    Clinical update
  5. MiLES — Phase 3

    Clinical update
  6. GX-03 — Phase 2

    Clinical update

Trial registry

6 studies